JBC Oz Biosciences

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M510320200 on February 13, 2006

J. Biol. Chem., Vol. 281, Issue 15, 10222-10229, April 14, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/15/10222    most recent
M510320200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, G.
Right arrow Articles by Wu, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, G.
Right arrow Articles by Wu, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Ephrin-B1 Is Critical in T-cell Development*

Guang Yu{ddagger}1, Jianning Mao{ddagger}1, Yulian Wu{ddagger}§, Hongyu Luo{ddagger}2, and Jiangping Wu, A National Scholar of the FRSQ{ddagger}3

From the {ddagger}Laboratory of Immunology and the Nephrology Service of Notre Dame Hospital, Centre Hospitalier de l'Université de Montréal (CHUM), Montréal, Quebec H2L 4M1, Canada and the §Second Affiliated Hospital of Zhejiang University Medical College, Hangzhou 310009, China

Eph kinases are the largest family of receptor tyrosine kinases, and their ligands, ephrins (EFNs), are also cell surface molecules. In this study, we investigated the role of EFNB1 and the Ephs it interacts with (collectively called EFNB1 receptors) in mouse T-cell development. In the thymus, CD8 single positive (SP) and CD4CD8 double positive (DP) cells expressed high levels of EFNB1 and EFNB1 receptors, whereas CD4 SP cells had moderate expression of both. Soluble EFNB1-Fc in fetal thymus organ culture caused significant subpopulation ratio skew, with increased CD4 SP and CD8 SP and decreased DP percentage, while the cellularity of the thymus remained constant. Moreover, in EFNB1-treated fetal thymus organ culture, CD117+, CD25+, DP, CD4 SP, and CD8 SP cells all had significantly enhanced proliferation history, according to bromodeoxyuridine uptake. In vitro culture of isolated thymocytes revealed that EFNB1-Fc on solid-phase protected thymocytes from anti-CD3-induced apoptosis, with concomitant augmentation of several antiapoptotic factors, particularly in CD4 SP and CD8 SP cells; on the other hand, soluble EFNB1-Fc promoted anti-CD3-induced apoptosis, as was the case in vivo. This study reveals that EFNB1 and EFNB1 receptors are critical in thymocyte development.


Received for publication, September 20, 2005 , and in revised form, February 7, 2006.

* This work was supported by Canadian Institutes of Health Research (CIHR) Grants MOP57697 and MOP69089, the Kidney Foundation of Canada, the Heart and Stroke Foundation of Quebec, Juvenile Diabetes Research Foundation USA Grant 1-2005-197, and the J.-Louis Levesque Foundation (to J. W.). This work was also supported by group grants from the CIHR for New Emerging Teams in Transplantation and from Fonds de la Recherche en Santé du Québec (FRSQ) for Transfusional and Hemovigilance Medical Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 These two authors contributed equally to this work.

2To whom correspondence may be addressed: Laboratory of Immunology, Research Center, Notre-Dame Hospital, CHUM, Pavilion DeSève, Rm. Y-5616, 1560 Sherbrooke St. E., Montreal, Quebec H2L 4M1, Canada. Tel.: 514-890-8000 (ext. 27421); Fax: 514-412-7596; E-mail: hongyu.luo{at}umontreal.ca. 3To whom correspondence may be addressed: Laboratory of Immunology, Research Center, Notre-Dame Hospital, CHUM, Pavilion DeSève, Rm. Y-5616, 1560 Sherbrooke St. E., Montreal, Quebec H2L 4M1, Canada. Tel.: 514-890-8000 (ext. 25164); Fax: 514-412-7596; E-mail: jianping.wu{at}umontreal.ca.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Leukoc. Biol.Home page
H. L. Holen, M. Shadidi, K. Narvhus, O. Kjosnes, A. Tierens, and H.-C. Aasheim
Signaling through ephrin-A ligand leads to activation of Src-family kinases, Akt phosphorylation, and inhibition of antigen receptor-induced apoptosis
J. Leukoc. Biol., October 1, 2008; 84(4): 1183 - 1191.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
G. Jiang, T. Freywald, J. Webster, D. Kozan, R. Geyer, J. DeCoteau, A. Narendran, and A. Freywald
In Human Leukemia Cells Ephrin-B-Induced Invasive Activity Is Supported by Lck and Is Associated with Reassembling of Lipid Raft Signaling Complexes
Mol. Cancer Res., February 1, 2008; 6(2): 291 - 305.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.